Latest Kaiser Health News Stories
Executive editor Damon Darlin takes a spin as host of “The Friday Breeze,” whirling through a week of health care news so you don’t have to.
Diabetics dying because they can’t afford insulin. Organ transplant patients undergoing “wallet biopsies” to get on waiting lists. Are out-of-pocket costs going to dominate the health discussion in the next election? Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss this as well as new Trump administration rules giving states the ability to make major changes to the Affordable Care Act. Also, lame-duck lawmakers in Wisconsin and Michigan try to cement health changes before Democrats take over.
The case of a Michigan woman told to fundraise $10,000 for a heart transplant sparked viral outrage, but experts say “wallet biopsies” are common.
The new-generation gadget is designed to alert and protect wearers from falls and heart problems, expanding Apple’s target audience beyond the usual, tech-savvy, early adopters to those with older tickers.
The incentive program to discourage nursing homes from discharging patients too quickly will also give bonuses to facilities with fewer rehospitalizations.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Do sales reps in the operating room lend helpful expertise or inflate already bloated costs? Depends on whom you ask.
The Trump administration offered states specific examples of how they could change the way they implement the Affordable Care Act. Critics say it could drive up premiums for many.
As consumers weigh health insurance options during open enrollment, location matters. Some parts of the country are seeing drops in premiums while others are experiencing another year of sticker shock.
In this episode of KHN’s “What the Health?” Mary Agnes Carey of Kaiser Health News, Margot Sanger-Katz of The New York Times, Alice Ollstein of Politico and Anna Edney of Bloomberg News discuss the impact of House Democratic leadership elections and their impact on health policy; as well as efforts by the Trump administration to address high drug prices and ensure the safety of medical devices. Plus, Julie Rovner interviews KHN’s Jay Hancock about the latest “Bill of the Month.”
Top House Republican also received more than $1 million from drugmakers since 2007.
The story of an Ohio mom who faced an outrageous bill for a new medicine for multiple sclerosis is the latest installment in the “Bill of the Month” series, an ongoing crowdsourced investigation by KHN and NPR.
Shereese Hickson’s doctor wanted her to try the infusion drug Ocrevus for her multiple sclerosis. Even though Hickson is trained as a medical billing coder, she was shocked to see two doses of the drug priced at $123,019, with her share set at $3,620.
A woman had twins in a hospital south of Boston, and for doctors aiming to reduce cesarean sections, the second baby’s tricky arrival tested the limits of teamwork.
The complete findings of a recent study show the FDA-approved drug Vascepa reduced the likelihood of cardiovascular death, stroke and other heart conditions in some patients. But science didn’t find the same promise for over-the-counter fish oil supplements when tested in healthy people.
Policyholders reason that their health is good — for now — and they don’t see the need for costly comprehensive coverage. Detractors say the plans undermine the Affordable Care Act, and agents advise reading the fine print. “You basically have to be in perfect health,” says one.
KHN’s Sarah Jane Tribble discusses the twists and turns with CBS News.
The dialysis industry raised nearly $111 million in a successful bid to defeat the measure, which also was opposed by hospitals and doctors. The union that sponsored the measure collected about one-sixth that amount.
Democrats, who have a history of championing the Affordable Care Act and railing about drug prices, will now chair several house committees.
KHN’s news analysis on “Medicare-for-all” sparks a broader conversation.